This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Codiak Biosciences, Inc., Vl27, Inc.. Active years: 2015-2020.
Location History:
- Molnlycke, SE (2018)
- Mölnlycke, SE (2015 - 2019)
- Boston, MA (US) (2020)
Company Filing History:
Years Active: 2015-2020
Title: Jan Lötvall: Innovator in Gene Modulation and Therapy
Introduction
Jan Lötvall is a prominent inventor based in Molnlycke, Sweden. He has made significant contributions to the field of gene modulation and therapy, holding a total of 6 patents. His work focuses on innovative methods for delivering therapeutic agents and genetic material to cells, which has important implications for medical treatments.
Latest Patents
Lötvall's latest patents include groundbreaking methods for exosome transfer of nucleic acids to cells. These methods are designed for gene modulation and therapy, including gene silencing and the introduction of genetic material to compensate for abnormal genes. Another notable patent involves the delivery of therapeutic agents through nanovesicles that contain oligonucleotide inhibitors targeting oncogenes. This method allows for the effective targeting of cancer cells, enhancing the potential for successful treatment.
Career Highlights
Throughout his career, Jan Lötvall has worked with several notable companies, including Codiak Biosciences, Inc. and Vl27, Inc. His expertise in the field has positioned him as a key figure in the development of innovative therapeutic solutions.
Collaborations
Lötvall has collaborated with esteemed colleagues such as Hadi Valadi and Jonas Andrej Nilsson. These partnerships have furthered his research and contributed to advancements in gene therapy.
Conclusion
Jan Lötvall's contributions to the field of gene modulation and therapy are noteworthy. His innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches in treating genetic disorders and cancer.